Market Cap

CureVac N.V. Market Capitalization:

€896.1 Million

EUR as of Jan. 1, 2024

US$989.7 Million

business CureVac N.V. Company Profile

CureVac N.V. Main Stock Listing

FSX: 5CV

Market Capitalization History of CureVac N.V.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of CureVac N.V. market cap

Date Market Cap YoY Change
Jan. 1, 2024 €896.1 M -57.75%
Jan. 1, 2023 €2.12 B -32.79%
Jan. 1, 2022 €3.16 B -76.67%
Jan. 1, 2021 €13.53 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

CureVac N.V. Categories

Germany languages Healthcare languages Biotechnology
Germany Healthcare Germany Biotechnology

Stocks & Indices

CureVac N.V. has the following listings and related stock indices.


Stock: FSX: 5CV

Stock: NASDAQ: CVAC

Stock: XETR: 5CV

Stock: BMV: CVACN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.